You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指跌幅擴至260點 藥明生物(02269.HK)急挫29%尋底
市場觀望美國本週通脹數據,道指昨晚在銀行及工業與油股支撐反覆回穩;但大型科技股疲弱,拖累納指及標普低收倒跌0.6%及0.4%。然而,亞太區股市普遍造好,但中港股市受壓。 香港1月PMI顯示私營經濟景氣一年來首呈萎縮,由前值50.8,急降至48.9。恆指繼昨天在中資銀行與電訊股及「三桶油」受捧支撐反覆續升6點後,今早低開31點或0.1%報24,548欠承接,跌幅擴大,最低見24,315,現報24,318,跌260點或1.1%,成交額430億元。 藍籌股個別發展,藥明生物(02269.HK)附屬公司遭美國商務部納入「未覈實清單」。該股今早大裂口低開14.8%報68.7元,跌幅擴大,最低見55元創約年半低, 現報57.45元,急挫29%,成交增至7,338萬股。 阿裏健康(00241.HK)回吐6.4%報5.85元,股價重失10天線;阿裏巴巴(09988.HK)續吐3.2%報111.4元。騰訊(00700.HK)及美團(03690.HK)續吐1.3%及2.1%分別報471.6元及221元。此外,比亞迪(01211.HK)終止三連升,今早股價隨其A股回吐3.6%報232.8元,重失10天線(239.5元)。 然而,匯控(00005.HK)、中國平安(02318.HK)、友邦(01299.HK)及國壽(02628.HK)續升逾1%,前者高見58.8元創兩年高。 長和(00001.HK)、金沙(01928.HK)及萬洲(00288.HK)升逾2%-3.5%,前者曾高見56.95元,股價重越10天線。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account